Filing Details

Accession Number:
0001181431-12-014029
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-02 19:09:11
Reporting Period:
2012-02-24
Filing Date:
2012-03-02
Filing Date Changed:
2012-03-02
Accepted Time:
2012-03-02 19:09:11
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486359 Jeno Gyuris C/o Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Svp, Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Disposition 2012-02-29 1,000 $13.18 90,612
Common Stock Disposition 2012-03-01 2,000 $13.33 88,612
Common Stock Disposition 2012-03-02 2,100 $13.16 86,512
Footnotes
  1. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.10 to $13.25 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.32 to $13.34 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.16 to $13.20 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!

Billionaire Hedge Funds